These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20407270)

  • 1. Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus.
    Bussières L; Bordas-Le Floch V; Bulder I; Chabre H; Nony E; Lautrette A; Berrouet C; Nguefeu Y; Horiot S; Baron-Bodo V; Van Overtvelt L; De Conti AM; Schlegel A; Maguet N; Mouz N; Lemoine P; Batard T; Moingeon P
    Int Arch Allergy Immunol; 2010; 153(2):141-51. PubMed ID: 20407270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
    Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
    Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Der p 21, a new important allergen derived from the gut of house dust mites.
    Weghofer M; Dall'Antonia Y; Grote M; Stöcklinger A; Kneidinger M; Balic N; Krauth MT; Fernández-Caldas E; Thomas WR; van Hage M; Vieths S; Spitzauer S; Horak F; Svergun DI; Konarev PV; Valent P; Thalhamer J; Keller W; Valenta R; Vrtala S
    Allergy; 2008 Jun; 63(6):758-67. PubMed ID: 18445190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines.
    Walgraffe D; Mattéotti C; El Bakkoury M; Garcia L; Marchand C; Bullens D; Vandenbranden M; Jacquet A
    J Allergy Clin Immunol; 2009 May; 123(5):1150-6. PubMed ID: 19152967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy.
    Weghofer M; Grote M; Dall'Antonia Y; Fernández-Caldas E; Krauth MT; van Hage M; Horak F; Thomas WR; Valent P; Keller W; Valenta R; Vrtala S
    Int Arch Allergy Immunol; 2008; 147(2):101-9. PubMed ID: 18520154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.
    Chen KW; Fuchs G; Sonneck K; Gieras A; Swoboda I; Douladiris N; Linhart B; Jankovic M; Pavkov T; Keller W; Papadopoulos NG; Valent P; Valenta R; Vrtala S
    Mol Immunol; 2008 May; 45(9):2486-98. PubMed ID: 18295887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapy.
    Bordas-Le Floch V; Bussières L; Airouche S; Lautrette A; Bouley J; Berjont N; Horiot S; Huet A; Jain K; Lemoine P; Chabre H; Batard T; Mascarell L; Baron-Bodo V; Tourdot S; Nony E; Moingeon P
    Int Arch Allergy Immunol; 2012; 158(2):157-67. PubMed ID: 22286395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions.
    Weghofer M; Thomas WR; Pittner G; Horak F; Valenta R; Vrtala S
    Clin Exp Allergy; 2005 Oct; 35(10):1384-91. PubMed ID: 16238800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of native and modified recombinant Der p 1 molecules in tobacco plants.
    Burtin D; Chabre H; Olagnier B; Didierlaurent A; Couret MN; Comeau D; Wambre E; Laparra H; Van Overtvelt L; Montandon F; Batard T; Jonval V; Lorphelin A; Merle C; Berrouet C; Parry L; Gomord V; Van Ree R; Moingeon P
    Clin Exp Allergy; 2009 May; 39(5):760-70. PubMed ID: 19226276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy.
    Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME
    Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite.
    Jacquet A; Vanderschrick JF; Vandenbranden M; Elouahabi A; Magi M; Garcia L; Ruysschaert JM
    Mol Ther; 2005 Jun; 11(6):960-8. PubMed ID: 15922967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and IgE binding analyses of recombinant Der p 2 expressed from the hosts Escherichia coli and Pichia pastoris.
    Tanyaratsrisakul S; Malainual N; Jirapongsananuruk O; Smith WA; Thomas WR; Piboonpocanun S
    Int Arch Allergy Immunol; 2010; 151(3):190-8. PubMed ID: 19786799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones.
    Yssel H; Johnson KE; Schneider PV; Wideman J; Terr A; Kastelein R; De Vries JE
    J Immunol; 1992 Feb; 148(3):738-45. PubMed ID: 1370514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies.
    Kerekov N; Michova A; Muhtarova M; Nikolov G; Mihaylova N; Petrunov B; Nikolova M; Tchorbanov A
    Immunobiology; 2014 Jan; 219(1):45-52. PubMed ID: 24021574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of IgE reactivity profiles among European mite allergic patients.
    Weghofer M; Thomas WR; Kronqvist M; Mari A; Purohit A; Pauli G; Horak F; Grönlund H; van Hage M; Valenta R; Vrtala S
    Eur J Clin Invest; 2008 Dec; 38(12):959-65. PubMed ID: 19021722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and characterization of full-length cDNAs encoding a novel high-molecular-weight Dermatophagoides pteronyssinus mite allergen, Der p 11.
    Tsai LC; Peng HJ; Lee CS; Chao PL; Tang RB; Tsai JJ; Shen HD; Hung MW; Han SH
    Allergy; 2005 Jul; 60(7):927-37. PubMed ID: 15932384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Der p 1 is the primary activator of Der p 3, Der p 6 and Der p 9 the proteolytic allergens produced by the house dust mite Dermatophagoides pteronyssinus.
    Herman J; Thelen N; Smargiasso N; Mailleux AC; Luxen A; Cloes M; De Pauw E; Chevigné A; Galleni M; Dumez ME
    Biochim Biophys Acta; 2014 Mar; 1840(3):1117-24. PubMed ID: 24291687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell epitopes of house dust mite major allergen Der p II.
    Joost van Neerven R; van t'Hof W; Ringrose JH; Jansen HM; Aalberse RC; Wierenga EA; Kapsenberg ML
    J Immunol; 1993 Aug; 151(4):2326-35. PubMed ID: 7688399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilution method to refold bacterially expressed recombinant Der f 2 and Der p 2 to exhibit the secondary structure and histamine-releasing activity of natural allergens.
    Takai T; Takaoka M; Yasueda H; Okumura K; Ogawa H
    Int Arch Allergy Immunol; 2005 May; 137(1):1-8. PubMed ID: 15785076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.